Log in:
Connecting and Supporting Pharma SMC all accross Europe
Small fonts
Normal fonts
Large fonts
RSS feed
Print page
Online Help
Sitemap « 

Europharm SMC - EPLS B2B Meeting

On the 21st of September 2016 in Brussels Europharm SMC will organise an important B2B Meeting session just before the 8th European Pharma Licensing Symposium.

This session will be organized in collaboration with PLG Europe (The Pharmaceutical Licensing Group) which is the original business development licensing group for the Healthcare industry. 

This co-organized B2B meeting will be a great opportunity for PLG and Europharm SMC members but also for non-members companies, to meet, to network...and to do business.

This meeting is open for all companies (Europharm SMC and PLG members and non-members)!!!

General Organization 

Both meetings (Europharm SMC B2B meeting and the 8th European Pharma Licensing Symposium) will take place at the Radisson Blue Royal Hotel in Brussels.

On the 21st September you are invited for a buffet lunch starting at 12.30 and the B2B meeting session will start at 2.00pm until 6.00pm.  Twelve One-to-one meetings of 20min each will be organized.

In the evening, from 6.30pm, all participants will be invited to join the 8th European Pharma Licensing Symposium Welcome Drinks & Networking Reception.

You'll find the Booking form for the Europharm SMC B2B meeting session here below.

All Europharm members are also welcome to participate to the 8th European Pharma Licensing Symposium on the 21st & 22nd September 2016. For Europharm members we have negotiate a special discounted delegate fee the delegate fee ending 30th June of 765 euros instead of 915 euros !!   You'll find also the Programme and the Booking form here below.

Please feel free to contact us directly for any additional information you may need and we are already looking forward to meeting you in September 2016 in Brussels,

All the Europharm SMC team

 Booking Form 8th Pharma Symposium
 Booking Form B2B Meetings
 Booking Form B2B Meetings PLG members
 Programme 8th Pharma Licensing Symposium